Abstract
We report a patient with systemic lupus erythematosus (SLE) who developed fulminant pulmonary hemorrhage. This patient also showed liver dysfunction, bicytopenia and hyperferritinemia, with an increase in serum levels of interleukin (IL)-1β, IL-6 and tumor necrosis factor-α (TNF-α) at the onset of pulmonary symptoms, probably indicating an associated hemophagocytic syndrome. Despite an acute progressive course temporarily requiring mechanical ventilation the patient was successfully treated with continuous drip infusion of tacrolimus, plasmapheresis and intravenous high-dose immunoglobulin and corticosteroid. In this patient increased inflammatory cytokines ascribable to activation of macrophages and/or helper T cells were considered to play an important role in the pathogenesis of the pulmonary hemorrhage. Because this complication is frequently fatal in SLE, intensive therapy, including immunosuppressants and plasmapheresis, should be actively considered as early as possible after onset.
Similar content being viewed by others
Abbreviations
- HPS:
-
Hemophagocytic syndrome
- SLE:
-
Systemic lupus erythematosus
- TNF:
-
Tumor necrosis factor
References
D’Cruz D, Khamashta M, Hughes G (2002) Pulmonary manifestations of systemic lupus erythematosus. In: DJ Wallace et al (eds) Dubois’ lupus erythematosus, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 663–683
Domingo-Pedrol P, Rodriguez de la Serna A, Mancebo-Cortes J, Sanchez-Segura JM (1985) Adult respiratory distress syndrome caused by acute systemic lupus erythematosus. Eur J Respir Dis 67:141–144
Asherson RA, Ridley M, Fletcher CD, Hughes GR (1988) Systemic lupus erythematosus, pulmonary hypertension and adult respiratory distress syndrome (ARDS). Clin Exp Rheumatol 6:301–304
Kim WU, Kim SI, Yoo WH et al. (1999) Adult respiratory distress syndrome in systemic lupus erythematosus: causes and prognostic factors: a single center, retrospective study. Lupus 8:552–557
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
Hallegua DS, Wallace DJ (2002) Gastrointestinal and hepatic manifestations. In: DJ Wallace et al (eds) Dubois’ lupus erythematosus, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 843–861
Henter J-I, Elinder G, Öst Å (1999) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 18:29–33
Ravelli A (2002) Macrophage activation syndrome. Curr Opin Rheumatol 14:548–552
Green RJ, Ruoss SJ, Kraft SA, Duncan SR, Berry GJ, Raffin TA (1996) Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest 110:1305–1316
Jara LJ, Vera-Lastra O, Calleja MC (2003) Pulmonary-renal vasculitic disorders: differential diagnosis and management. Curr Rheumatol Rep 5:107–115
Lauqua D, Cadranel J, Lazor R et al. (2000) Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Medicine (Baltimore) 79:222–233
Eagen JW, Memoli VA, Roberts JL, Matthew GR, Schwartz MM, Lewis EJ (1978) Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 57:545–560
Moss M, Ingram RH Jr (2001) Acute respiratory distress syndrome. In: E Braunwald et al. (eds) Harrison’s principles of internal medicine, 15th edn. McGraw-Hill, New York, pp 1523–1526
Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM (1992) A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 326:1373–1379
Erickson RW, Franklin WA, Emlen W (1994) Treatment of hemorrhagic lupus pneumonitis with plasmapheresis. Semin Arthritis Rheum 24:114–123
Dalakas MC (1998) Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 51(Suppl): S2–8
Kilian K, Banyai A, Karadi A, Miklos K, Patranyi GG, Paloczi K (1998) FK-506 (tacrolimus) therapy for an unusual SLE-like disease. Transplant Proc 30:4130–4131
Griffiths B, Emery P (2001) The treatment of lupus with cyclosporin A. Lupus 10:165–170
Manger K, Kalden JR, Manger B (1996) Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study. Br J Rheumatol 35:669–675
Schreiber SL, Crabtree GR (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136–142
Moon JI, Park SG, Cheon KO (2000) Pregnancy in renal transplant patients. Transplant Proc 32:1869–1870
Yasuhara M, Hashida T, Toraguchi M et al. (1995) Pharmacokinetics and pharmacodynamics of FK506 in pediatric patients receiving living-related donor liver transplantation. Transplantation Proc 27:1108–1110
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hoshi, Ki., Matsuda, M., Ishikawa, M. et al. Successful treatment of fulminant pulmonary hemorrhage associated with systemic lupus erythematosus. Clin Rheumatol 23, 252–255 (2004). https://doi.org/10.1007/s10067-003-0859-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-003-0859-2